Measurement of Cut-off Perfusion Index Value in Infraclavicular Blocks

February 1, 2022 updated by: MEHMET DURAN, Adiyaman University

To Investigate the Value of the Cut-off Perfusion Index Showing That the Block is Successful in Infraclavicular Blocks Performed Under Ultrasound Guidance.

To investigate the value of the cut-off perfusion index showing that the block is successful in infraclavicular blocks performed under ultrasound guidance.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

In upper extremity procedures, ultrasound (US) guided infraclavicular block is a frequently used approach. Today, the frequency of studies on the perfusion index (PI), which can be used as a criterion in the evaluation of block success, is increasing. The aim of this study is to evaluate the success and effectiveness of infraclavicular approach block with perfusion index using ROC (Receiver Operating Characteristic) curves.

Study Type

Observational

Enrollment (Anticipated)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Adıyaman, Turkey
        • Adıyaman University Recruitment

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

ASA1-2 50 PATIENTS BETWEEN 18-65 YEARS

Description

Inclusion Criteria:

  • ASA 1-2 PATIENTS
  • PATIENTS BETWEEN 18-65 YEARS
  • PATIENTS WITH INFRACLAVICULAR BLOCK

Exclusion Criteria:

  • ASA3-4 PATIENTS
  • PATIENTS UNDER THE AGE OF 18, PATIENTS OVER 65
  • PATIENTS WHO DO NOT WANT TO BE INCLUDED IN THE STUDY
  • PATIENTS WITH CONTRAINDICATION TO INFRACLAVICULAR BLOCK
  • PATIENTS WITHOUT COOPERATION
  • PATIENTS WITH DIABETES MELLITUS
  • THOSE WHO HAVE PERIPHERAL ARTERY DISEASE

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To Investigate the Value of the Cut-off Perfusion Index Showing That the Block is Successful in Infraclavicular Blocks Performed Under Ultrasound Guidance
Time Frame: Perfusion index, pulse and blood pressure will be measured 5-10-20 minutes after the block is made.
To measure perfusion index values in patients aged 18-65 years who underwent upper extremity surgery
Perfusion index, pulse and blood pressure will be measured 5-10-20 minutes after the block is made.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Adiyaman University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Anticipated)

April 15, 2022

Study Completion (Anticipated)

November 15, 2022

Study Registration Dates

First Submitted

February 1, 2022

First Submitted That Met QC Criteria

February 1, 2022

First Posted (Actual)

February 10, 2022

Study Record Updates

Last Update Posted (Actual)

February 10, 2022

Last Update Submitted That Met QC Criteria

February 1, 2022

Last Verified

July 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020/6-18
  • ISEYHANLI (Other Identifier: AdiyamanU)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Extremity Surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe